None listed
Conditions
Brief summary
The purpose of this study is to collect data for cancer patients with heart risks and compare this data to other people without cancer. Who is it for? You may be eligible for this study if you are an adult who has either been diagnosed with cancer or has never been diagnosed with cancer. Study details Participants with cancer will take part in blood tests, echocardiogram, ECG, and vital sign assessments as part of their standard care and questionnaires, while participants without cancer will take the same asssessments of which results will be availabe through medical record or your treating team in many cases. All participants will also be asked to complete an interview at baseline and be followed up for 6 months, 12 months and 24 months which includes vital signs, blood tests, ECG, echocardiongram,and questonnaires. If the test results are available, we'll collect data through medical records, however it these are not available, participants are asked to do the tests. It is hoped that this study will help provide data that will be able to be used to reduce risk of side effects including the heart, while also reducing interruptions to cancer treatment.
Interventions
Patients' involvement is needed because this study is collecting data prospectively from medical record, treating teams, patients and CHeReL for linked data. In most case these data will be available from the treating team. If the data such as reaults of blood test, ECG or echocardiogram is not available, patients will be asked to do the tests.
Data to be colleted are medical history, cancer type and status, cancer treatment, vital signs, medication, ECG, echogardiogram, cardiovacular risk fac
Patients' involvement is needed because this study is collecting data prospectively from medical record, treating teams, patients and CHeReL for linked data. In most case these data will be available from the treating team. If the data such as reaults of blood test, ECG or echocardiogram is not available, patients will be asked to do the tests. Data to be colleted are medical history, cancer type and status, cancer treatment, vital signs, medication, ECG, echogardiogram, cardiovacular risk factors, blood tests, diet, questionnaires, cardiovascular events and cause of death. Questionairres include short IPAQ, ECOG and PHQ-9 anticipated to take 15 minutes at enrollment, 12 months and 24 month. The overall duration is 24 months from time of enrollement.
Sponsors
University of Sydney
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
Inclusion Criteria (cases): 1. Patients that are of 18 years of age and older. 2. The following oncological diagnoses a. Prostate, bladder, testicular, lung, breast, and colorectal cancers 3. Receiving cancer therapy or have received cancer therapy within the last 5 years 4. Patients are willing to follow up at the enrolling center. Inclusion Criteria (controls): 1. Participants that are of 18 years of age and older 2. No current or previous oncological diagnosis at baseline
Exclusion criteria
1. Patient will not be following up at the participating site 2. Incapacity to provide written informed consent due to reasons other than language barriers
Outcome results
None listed